Literature DB >> 24599433

At high altitude in the Netherlands: secondary erythrocytosis due to HB-Malmö.

Bart Santbergen1, Cees van der Heul.   

Abstract

We describe two patients, a father and a son, presenting with erythrocytosis. Evaluation showed no pulmonal or cardial disorders. Owing to an elevated erythropoietin level after phlebotomy, a physiological secondary polycythaemia was suspected. A haemoglobin electrophoresis showed that our patients have a haemoglobinopathy with high affinity for oxygen, called Hb-Malmö (exon 3: c.294 C>G p.His98Gln). Hb-Malmö is a congenital disorder located on a gene at chromosome 11, in the B-chain on codon 97, decoding the α-subunit and β-subunit of the haemoglobin. Through a mutation (CAC→CAG), histidine is replaced by glutamine. The mutation causes a disorder in the connection between the α1-subunit and β2-subunit of the haemoglobin structure. These connections are important sites for binding oxygen. Mutated haemoglobin has a preference for an oxygenated status, which implicates that there is an increased binding and decreased release of oxygen. To compensate, there will be an erythrocytosis to transport sufficient oxygen to the peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599433      PMCID: PMC3948139          DOI: 10.1136/bcr-2014-203701

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Letter: A new kindred with hemoglobin Malmö (beta97 leads to Gln).

Authors:  M K McCormack; S J Zak; G R Geller; D P Tukey; W Krivit
Journal:  J Pediatr       Date:  1976-06       Impact factor: 4.406

2.  [Abnormal hemoglobins with high oxygen affinity in the differential diagnosis of polycythemia].

Authors:  A Esparcieux; A Francina; D Vital-Durand
Journal:  Rev Med Interne       Date:  2011-04-20       Impact factor: 0.728

3.  Double heterozygosity for haemoglobin Malmø and beta-thalassaemia traits, with unusually high haematocrit values, in a Sicilian man.

Authors:  M Girino; A Riccardi; A Mosca; R Paleari; P Bonomo
Journal:  Eur J Haematol       Date:  1988-08       Impact factor: 2.997

4.  Erythrocytosis associated with haemoglobin Malmö, accompanied by pulmonary changes, occurring in the same family.

Authors:  S Berglund
Journal:  Scand J Haematol       Date:  1972

5.  Familial erythrocytosis due to electrophoretically undetectable hemoglobin with impaired oxygen dissociation (hemoglobin Malmö, alpha 2 beta 2 97 gln).

Authors:  V F Fairbanks; J E Maldonado; S Charache; S H Boyer
Journal:  Mayo Clin Proc       Date:  1971-11       Impact factor: 7.616

6.  Two new pathological haemoglobins: Olmsted beta 141 (H19) Leu leads to Arg and Malmö beta 97 (FG4) His leads to Gln.

Authors:  P A Lorkin; H Lehmann
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

7.  Relationship between tetramer-dimer assembly and the stability of Hb Malmö (alpha 2 beta 2 97Gln).

Authors:  K Adachi; H Vonk; M P Reilly; H Adachi; W A Schroeder; E Schwartz; T Asakura
Journal:  Biochim Biophys Acta       Date:  1984-10-23

8.  Double heterozygosity for hemoglobin Malmö [beta 97 (FG 4) His----Gln] and beta-thalassemia traits.

Authors:  M Girino; A Riccardi; A Mosca; R Paleari; P Bonomo
Journal:  Haematologica       Date:  1989 Mar-Apr       Impact factor: 9.941

9.  A hypothesis for the increased oxygen affinity in haemoglobin Malmö.

Authors:  S J Zak; G R Geller; W Krivit; D Tukey; B Brimhall; R T Jones; H F Bunn; M McCormack
Journal:  Br J Haematol       Date:  1976-05       Impact factor: 6.998

10.  [Polycythemia resulting from abnormal hemoglobin with increased affinity for oxygen. Two cases (author's transl)].

Authors:  G Gacon; H Wajcman; O Belkhodja-Dunda; D Labie; J Bousser
Journal:  Nouv Presse Med       Date:  1980-01-26
View more
  1 in total

1.  Muscle oxygenation during normoxic and hypoxic cycling exercise in humans with high-affinity haemoglobin.

Authors:  Kevin L Webb; Ahmed N Elshaer; Paolo B Dominelli; Jonathon W Senefeld; Shane M Hammer; Sarah E Baker; John R A Shepherd; Tuhin K Roy; Michael J Joyner; Chad C Wiggins
Journal:  Exp Physiol       Date:  2022-06-03       Impact factor: 2.858

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.